Kevin T. Conroy - Dec 31, 2020 Form 5 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark Busch, attorney-in- fact
Stock symbol
EXAS
Transactions as of
Dec 31, 2020
Transactions value $
$0
Form type
5
Date filed
4/29/2025, 04:09 PM
Previous filing
Apr 29, 2025
Next filing
Jun 3, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Gift $0 -163K -21.3% $0.00 602K Oct 26, 2020 Direct F1
holding EXAS Common Stock 26.3K Dec 31, 2020 Held in 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In addition to the shares of Common Stock reported on this Form 5, which total 628,425 shares, Mr. Conroy also held, in the aggregate, an additional 1,279,310 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.